Clara Maluquer
Impact in
- Oncology top 10%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Neutropenia and Cancer Infections
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 10
- COVID-19 and healthcare impacts 8
- Neutropenia and Cancer Infections 2
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Alberto Mussetti (3 shared papers)Anna Sureda-Balarí (6 shared papers)Adaia Albasanz‐Puig (1 shared paper)Paolo Corradini (1 shared paper)Carlota Gudiol (1 shared paper)Gabriel Moreno‐González (2 shared papers)Lurdes Zamora (2 shared papers)Francesc Gessé Solé (1 shared paper)
- Journals
- The Lancet Oncology (3 papers)HemaSphere (2 papers)Bone Marrow Transplantation (2 papers)British Journal of Haematology (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- SpainItalyUnited Kingdom
In The Last Decade
Clara Maluquer
24 papers receiving 529 citations
Peers
Comparison fields: 5 of 56
- Oncology 271
- Infectious Diseases 190
- Neurology 62
- Applied Microbiology and Biotechnology 6
- Hematology 25
Countries citing papers authored by Clara Maluquer
This map shows the geographic impact of Clara Maluquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Maluquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Maluquer more than expected).
Fields of papers citing papers by Clara Maluquer
This network shows the impact of papers produced by Clara Maluquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Maluquer. The network helps show where Clara Maluquer may publish in the future.
Co-authors
The 25 scholars most cited alongside Clara Maluquer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 153 | |
| 2 | 2021 | 92 | |
| 3 | 2022 | 67 | |
| 4 | 2021 | 35 | |
| 5 | 2022 | 28 | |
| 6 | 2023 | 25 | |
| 7 | 2022 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2021 | 16 | |
| 10 | 2024 | 15 | |
| 11 | 2020 | 14 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2024 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2021 | 5 | |
| 17 | 2017 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 3 | |
| 20 | 2019 | 2 |
About Clara Maluquer
Clara Maluquer is a scholar working on Oncology, Hematology, Infectious Diseases, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 26 papers that have together received 534 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (8 papers), COVID-19 Clinical Research Studies (6 papers), Acute Lymphoblastic Leukemia research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Long-Term Effects of COVID-19 (3 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Oncology (271 citations), Infectious Diseases (190 citations), Neurology (62 citations), Applied Microbiology and Biotechnology (6 citations) and Hematology (25 citations). Clara Maluquer has collaborated with scholars based in Spain, Italy and United Kingdom. Frequent co-authors include Alberto Mussetti, Anna Sureda-Balarí, Adaia Albasanz‐Puig, Paolo Corradini, Carlota Gudiol, Gabriel Moreno‐González, Lurdes Zamora, Francesc Gessé Solé, Jordi Juncà and Ramón García‐Sánz. Their work appears in journals such as The Lancet Oncology, HemaSphere, Bone Marrow Transplantation, British Journal of Haematology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.